Anjali Raja Beharalle
Anjali Raja Beharalle
This is a clinical study to improve the regularity of medication intake for high blood pressure. Adult women and men who are over 50 years old, who have received a prescription drug for high blood pressure from MediService, and who have to take at least 4 tablets per day (of which at least 1 dose of medication per day is for high blood pressure) can participate in this study. The investigators intend to examine whether Collabree, a mobile phone application, is effective in supporting patients with hypertension to more successfully following their therapy plan in order to improve the regularity of medication intake. The study includes a 90-day intervention phase and a 90-day follow-up. The study does not require any therapy adjustments and no visits to a study center are necessary. The participants conduct the study independently at home. Participants will also fill out questionnaires. Participants are randomly assigned to one of 3 groups in a ratio of 1: 1: 1. Two of these groups will receive the Collabree mobile phone application.
Hypertension
Medication Adherence
Collabree Mobile Phone Application Medication Adherence Booster
Collabree Mobile Phone Application Medication Adherence Booster (simplified version)
Not Applicable
Study Type : | Interventional |
Estimated Enrollment : | 180 participants |
Masking : | None (Open Label) |
Primary Purpose : | Prevention |
Official Title : | Collabree: A Targeted Behavioral Economics-based Remote Intervention to Improve Medication Adherence in Patients With Hypertension |
Actual Study Start Date : | March 10, 2022 |
Estimated Primary Completion Date : | August 2024 |
Estimated Study Completion Date : | November 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Intervention Group A Patients receive the Collabree mobile phone application with a specific set of functions. |
|
Experimental: Intervention Group B Patients receive the Collabree mobile phone application with a specific set of functions. |
|
No Intervention: Control Group Patients will not receive the Collabree application. |
Ages Eligible for Study: | 50 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Collabree AG
Zürich, Switzerland, 8002